Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.375 AUD | -3.85% | -1.32% | -8.54% |
Apr. 15 | Orthocell Secures AU$3 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 3% | MT |
Apr. 09 | Orthocell Revenue Soars 19% to AU$1.61 Million in Q1 | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Regenerative Medicine
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +31.47% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +31.47% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ming Hao Zheng
FOU | Founder | - | 06-03-20 |
Paul Anderson
FOU | Founder | 58 | 06-03-20 |
Nicole Telford
DFI | Director of Finance/CFO | - | 06-02-28 |
Alex McHenry
COO | Chief Operating Officer | - | 15-12-31 |
Tim Kelaher
PRN | Corporate Officer/Principal | - | - |
Gregor Maier
SAM | Sales & Marketing | - | 14-11-30 |
Peter Webse
SEC | Corporate Secretary | 61 | 23-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 23-10-24 | |
Chairman | - | 23-05-31 | |
Ravi Thadhani
BRD | Director/Board Member | - | 23-03-07 |
Paul Anderson
FOU | Founder | 58 | 06-03-20 |
Director/Board Member | 75 | Jan. 14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 338,600 | 0 | 0 | 74.71 % |
Stock B | 1 | 199,267,357 | 148,880,078 ( 74.71 %) | 0 | |
Stock C | 0 | 1,361,230 | 0 | 0 |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.54% | 54.05M | |
+10.44% | 106B | |
+0.82% | 104B | |
+6.72% | 23.25B | |
-13.89% | 22.5B | |
-6.64% | 18.7B | |
-37.26% | 17.95B | |
-10.98% | 16.99B | |
+8.67% | 14.26B | |
+41.08% | 12.76B |
- Stock Market
- Equities
- OCC Stock
- Company Orthocell Limited